Global Patent Case Tracking and Litigation Research Platform

Mylan Pharmaceuticals Inc. et al. vs. Bausch Health Ireland Limited et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00722

Filing Date 2026-01-27

Decision Type Final Written Decision: JUDGMENT Final Written Decision on Remand Determining No Challenged Claims Unpatentable 35 U.S.C. §§ 144, 318 Granting Patent Owner’s Motion to Exclude 37 C.F.R. § 42.64(c)

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2026-01-12

Decision Type JUDGMENT Granting Petitioners Joint and Unopposed Motion to Withdraw and Request for Adverse Judgment After Institution of Trial and on Remand 37 C.F.R. § 42.73(b)

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2025-12-09

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bausch Health Ireland Limited et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00722

Filing Date 2025-07-29

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2025-01-10

Decision Type Termination Decision: Post-DI Settlement

PDF Track Case View Details

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 24-2351

Filing Date 2024-09-24

Cause / Court 35:271 Patent Infringement

Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01226

Filing Date 2024-08-23

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01225

Filing Date 2024-08-23

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2021-00881

Filing Date 2024-07-19

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2021-00880

Filing Date 2024-07-19

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 24-2058

Filing Date 2024-07-10

Cause / Court 35:271 Patent Infringement

Track Case View Details

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 24-2009

Filing Date 2024-06-26

Cause / Court 35:271 Patent Infringement

Track Case View Details

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 24-2002

Filing Date 2024-06-25

Cause / Court 35:271 Patent Infringement

Track Case View Details

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 24-1965

Filing Date 2024-06-20

Cause / Court 35:271 Patent Infringement

Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2024-05-28

Decision Type Institution decision and grant of joinder, IPR2024-00107

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2024-04-25

Decision Type Institution decision and grant of joinder, IPR2024-00009

PDF Track Case View Details

In Re: Aflibercept Patent Litigation

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 1:24-md-03103

Filing Date 2024-04-11

Cause / Court 28:1338 Patent Infringement

Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01226

Filing Date 2024-01-09

Decision Type Final Written Decision: original

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01225

Filing Date 2024-01-09

Decision Type JUDGMENT Final Written Decision Denying in Part, Granting in Part, and Dismissing in Part Petitioner’s Motion to Exclude Evidence, Denying in Part and Dismissing in Part Patent Owner’s Motion to Exclude Evidence, Determining Challenged Claims 1, 3–11, 13, 14, 16–24, and 26 Unpatentable 35 U.S.C. § 318(a)

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2023-10-04

Decision Type Institution Decision: Grant

PDF Track Case View Details